tirzepatide to semaglutide conversion Switching between weight-loss medications Semaglutide Weight Loss Dosage Chart

God Bless you man

J., van Dam, N

7 Subcutaneous semaglutide was approved in 2021 and 2022 as Wegovy for weight loss in patients 12 and older after the STEP1 trial showed patients who took subcutaneous semaglutide had a -14.9% body weight reduction (-15.3kg) compared to -2.4% (-2.6kg) with placebo after 68 weeks

If you use fiber supplements, start at a low dose and increase gradually while boosting fluid intake

Common side effects include: Mild nausea Improves over time as your body adapts Bloating & stomach discomfort Due to slowed digestion Constipation or diarrhea Managed with hydration and fiber intake Fatigue or dizziness Typically resolves with continued use Mild headaches Can occur with dosage increases If side effects persist, Dr